Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

Study Summary

A randomized, open-label, three-sequence, three-period, multiple dosing crossover, phase 1 clinical trial to evaluate the effect of DWP14012 on the pharmacodynamics of DWC202202 in combination with DWP14012 in healthy subjects